Mebendazole

Caitlin Soto, PharmD, BCIDP, Edina Avdic, Pharm.D.
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID

INDICATIONS

FDA

Note: The Vermox brand was withdrawn from the U.S. market in 2011; mebendazole subsequently returned to the U.S. market as Emverm (mebendazole 100 mg chewable tablet), FDA-approved in 2016. FDA-approved Vermox 500 mg chewable tablets are not commercially available in the U.S., but they are distributed as part of a global product donation program (led by Johnson & Johnson in partnership with the WHO) to endemic areas burdened by soil-transmitted helminths (STH). U.S. 100-mg and historically approved 500-mg formulations have different FDA-approved indications, dosing regimens, and labeling.

NON-FDA APPROVED USES

  • Established treatment options
  • Alternative therapies:
    • Echinococcus (cystic)
    • Mansonella perstans
    • Toxocariasis
    • Trichostrongyliasis
  • Historical or exceptional use:

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: November 14, 2026